menu
Interstitial Lung Disease | Affidea

EthicalMedTech

Official Endorsement

The Interstitial Lung Disease Multidisciplinary Meeting 2019 has been fully endorsed by EthicalMedTech after undergoing the conference vetting process, which examines the program and services offered during Scientific Sessions.

SEE ETHICALMEDTECH'S ENDORSEMENT OF THE ILD MEETING 2019

What isEthicalMedTech Conference Vetting System?

EthicalMedTech Conference Vetting System (CVS) is an independent entity that reviews the compliance of third-party educational events with bothMedTech Europe Code of Ethical Business PracticeandMecomed Code of Business Practiceto determine the appropriateness for companies which are members of MedTech Europe and Mecomed to sponsor Healthcare Professionals to participate in conferences. CVS aims to simplify and centralise decision-making for MedTech Europe and Mecomed members by establishing a single assessment procedure based on a set of criteria provisioned in the MedTech Europe Code of Ethical Business Practice. It also aims to harmonise the interpretation of the Code across the medical technology industry with the goals of greater consistency and transparency in industry behavior.

keyboard_arrow_left Go Back